Pages that link to "Q40508991"
Jump to navigation
Jump to search
The following pages link to Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma (Q40508991):
Displaying 13 items.
- Sex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet (Q28744059) (← links)
- PharmGKB summary: very important pharmacogene information for SLC22A1 (Q33671763) (← links)
- Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells (Q33815980) (← links)
- Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin. (Q34224429) (← links)
- Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications (Q36808739) (← links)
- OCT1 and imatinib transport in CML: is it clinically relevant? (Q38540022) (← links)
- Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy (Q38816602) (← links)
- Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation (Q38859468) (← links)
- Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor. (Q42503774) (← links)
- Increased Expression of Hepatic Organic Cation Transporter 1 and Hepatic Distribution of Metformin in High-fat Diet-induced Obese Mice (Q42918831) (← links)
- Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism (Q57146469) (← links)
- Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers (Q87240112) (← links)
- PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice (Q92812275) (← links)